Review Article
Revisiting the Posttherapeutic Cure Criterion in Chagas Disease: Time for New Methods, More Questions, Doubts, and Polemics or Time to Change Old Concepts?
Table 2
Categories of laboratorial methods and targets available for evaluation of the etiological treatment efficacy/benefits and their interpretation in the context of Chagas disease cure assessment.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conventional serological tests: CFR (complement fixation reaction), IHA (indirect hemagglutination assay), IIF (indirect immunofluorescence test), and ELISA (enzyme-linked immunosorbent assay); nonconventional serological tests: ML (complement mediated lysis), FC-ALTA (flow cytometry anti-live trypomastigotes antibodies), FC-AFEA (flow cytometry anti-fixed epimastigotes antibodies) and, FC-ATE (flow cytometry anti-live amastigote/trypomastigotes and fixed epimastigote antibodies); direct parasitological tests: fresh blood examination (FBE) and trypomastigotes concentration (buffy coat, microhematocrit, and Strout tests); indirect parasitological tests: xenodiagnosis, hemoculture, PCR, and qPCR; cellular immunology test: peripheral blood mononuclear cell and/or whole blood in vitro cultures in the presence of T. cruzi-derived antigens followed by cell surface phenotypic analysis and intracellular cytokine staining by flow cytometry. #Proinflammatory pattern refers to IFN- mediated immune response of NK-cells and CD8+ T-cells. Balanced profile refers to IL-10 modulated response by monocytes or B-cells. |